Aims/Introduction: The efficacy and safety of sitagliptin, a dipeptidyl peptidase (DPP)- 4 inhibitor, were compared with those of glinides in Japanese patients with type 2 diabetes. Materials and Methods: he participants were 82 patients with type 2 diabetes (glycated hemoglobin [HbA1c] ≥6.0% and
Aims/Introduction: The goal of the present study was to evaluate predictive factors for good efficacy and durability to sitagliptin with ongoing metformin or metformin plus glimepiride therapy in a real practice situation. The present observational study was carried out over a 60-week period and involved Korean patients with type 2 diabetes mellitus. Materials and Methods: A total of 100 mg of …